Ushering a revolution in detection and management of prostate cancer, the Chinese General Hospital and Medical Center (CGHMC) in Manila recently acquired the world’s first Koelis Trinity fusion biopsy technology with transperineal probe for clinical use, from Transmedic Philippines. “For the past 35 years, prostate cancer diagnosis requires a transrectal ultrasound-guided needle biopsy. The Koelis Trinity fusion biopsy technology allows for an unmatched superiority in the localization of prostate cancers. Since then, the accumulated results prove the Koelis Trinity fusion biopsy technology is superior. With its accuracy, effectiveness and patient safety, the procedure will be the new gold standard in prostate cancer detection today and in the years to come.
Source: Manila Times August 21, 2017 16:30 UTC